[1] Lonardo A,Ballestri S,Marchesini G,et al.Nonalcoholic fatty liver disease:a precursor of the metabolic syndrome. Dig Liver Dis,2015,47(3):181-190. [2] Ratziu V,Bellentani S,Cortez-Pinto H,et al.A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol,2010,53(2):372-384. [3] Buzzetti E,Pinzani M,Tsochatzis EA.The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD). Metabolism,2016,65(8):1038-1048. [4] 周达,陈源文,范建高. 脯氨酰寡肽酶的肝内生物学功能研究进展. 胃肠病学和肝病学杂志,2015,24(1):12-14. [5] Penttinen A,Tenorio-Laranga J,Siikanen A,et al.Prolyl oligopep tidase:a rising star on the stage of neuroinflammation research. CNS Neurol Disord Drug Targets,2011,10(3):340-348. [6] Zhou D,Li BH,Wang J,et al.Prolyl oligopeptidase inhibition attenuates steatosis in the L02 human liver cell line. PLoS One,2016,11(10):e0165224. [7] Xu ZJ,Fan JG,Ding XD,et al.Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci,2010,55(4):931-940. [8] Kleiner DE,Brunt EM,Van Natta M,et al.Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology,2005,41(6):1313-1321. [9] Brunt EM,Kleiner DE,Wilson LA,et al.Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD:distinct clinicopathologic meanings. Hepatology,2011,53(3):810-820. [10] Chen YW,Liu BW,Zhang YJ,et al.Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver. J Hepatol,2010,53(3):528-536. [11] Rotman Y,Sanyal AJ.Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut,2017,66(1):180-190. [12] Hofling C,Kulesskaya N,Jaako K,et al.Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume. Eur Neuropsychopharmacol,2016,26(6):1048-1061. [13] Kim JD,Toda C,D'Agostino G,et al. Hypothalamic prolyl endopeptidase(PREP) regulates pancreatic insulin and glucagon secretion in mice. Proc Natl Acad Sci U S A,2014,111(32):11876-11881. [14] Myohanen TT,Venalainen JI,Garcia-Horsman JA,et al.Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues. Histochem Cell Biol,2008,130(5):993-1003. [15] Gaggar A,Jackson PL,Noerager BD,et al.A novel proteolytic cascade generates an extracellular matrix-derived chemoattrac-tant in chronic neutrophilic inflammation. J Immunol,2008,180(8):5662-5669. [16] Weathington NM,van Houwelingen AH,Noerager BD,et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med,2006,12(3):317-323. [17] Ye D,Yang K,Zang S,et al.Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2. J Hepatol,2016,65(5):988-997. [18] 王晶,周达,丁永年,等. 慢病毒介导脯氨酰寡肽酶过表达抑制硫代乙酰胺诱导的大鼠肝纤维化. 实用肝脏病杂志,2015,18(2):168-172. |